Advancing the Evolution and Convergence of Artificial Intelligence and Optics
Reinventing Health Screening
It’s clear that overburdened and increasingly underfunded healthcare systems cannot continue to absorb the high costs of legacy imaging and genomic screening technologies. This is what motivated us to expand our SpotLight™ platform by initiating the development of a 30-second, non-invasive cancer screening test.
A Health Platform Based on Technology Innovation
Leveraging expensive and lengthy genomic-based technologies, our innovative mapping of proteomic changes enables low cost and immediate information for people seeking to manage their health. Just as SpotLight-19™ confirms infection by revealing proteomic changes unique to viral infection, we are developing capabilities to screen for cancer, drug impairment, and mental illness.
